Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Jul 18, 2021; 11(7): 254-262
Published online Jul 18, 2021. doi: 10.5500/wjt.v11.i7.254
Published online Jul 18, 2021. doi: 10.5500/wjt.v11.i7.254
Chances and risks of sodium-glucose cotransporter 2 inhibitors in solid organ transplantation: A review of literatures
Marlene Schwarzenbach, Flavia Elena Bernhard, Cecilia Czerlau, Daniel Sidler, Department of Nephrology and Hypertension, University Hospital Insel Bern, Bern 3010, Switzerland
Author contributions: Czerlau C and Sidler D designed the study; Schwarzenbach M and Bernhard FE performed the literature search; Schwarzenbach M, Bernhard FE, Czerlau C and Sidler D wrote the paper.
Conflict-of-interest statement: The authors declare no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Daniel Sidler, MD, PhD, Assistant Professor, Consultant Physician-Scientist, Senior Researcher, Department of Nephrology and Hypertension, University Hospital Insel Bern, Freiburgstrasse, Bern 3010, Switzerland. daniel.sidler@insel.ch
Received: January 11, 2021
Peer-review started: January 11, 2021
First decision: May 5, 2021
Revised: May 17, 2021
Accepted: May 26, 2021
Article in press: May 26, 2021
Published online: July 18, 2021
Processing time: 183 Days and 0.8 Hours
Peer-review started: January 11, 2021
First decision: May 5, 2021
Revised: May 17, 2021
Accepted: May 26, 2021
Article in press: May 26, 2021
Published online: July 18, 2021
Processing time: 183 Days and 0.8 Hours
Core Tip
Core Tip: Literature review of efficacy and side effects of sodium-glucose cotransporter 2 inhibitors in diabetes management specifically in solid organ recipients.